These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11479431)

  • 1. Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo.
    Bosserhoff AK; Echtenacher B; Hein R; Buettner R
    Melanoma Res; 2001 Aug; 11(4):417-21. PubMed ID: 11479431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo.
    Guba M; Bosserhoff AK; Steinbauer M; Abels C; Anthuber M; Buettner R; Jauch KW
    Br J Cancer; 2000 Nov; 83(9):1216-22. PubMed ID: 11027436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.
    Winklmeier A; Contreras-Shannon V; Arndt S; Melle C; Bosserhoff AK
    Cancer Sci; 2009 Feb; 100(2):261-8. PubMed ID: 19200257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MIA ("melanoma inhibitory activity"). Biological functions and clinical relevance in malignant melanoma].
    Bosserhoff AK; Golob M; Buettner R; Landthaler M; Hein R
    Hautarzt; 1998 Oct; 49(10):762-9. PubMed ID: 9857251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
    Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
    Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active detachment involves inhibition of cell-matrix contacts of malignant melanoma cells by secretion of melanoma inhibitory activity.
    Bosserhoff AK; Stoll R; Sleeman JP; Bataille F; Buettner R; Holak TA
    Lab Invest; 2003 Nov; 83(11):1583-94. PubMed ID: 14615412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
    Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma inhibitory activity (MIA): an important molecule in melanoma development and progression.
    Bosserhoff AK
    Pigment Cell Res; 2005 Dec; 18(6):411-6. PubMed ID: 16280006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes.
    Tatzel J; Poser I; Schroeder J; Bosserhoff AK
    Pigment Cell Res; 2005 Apr; 18(2):92-101. PubMed ID: 15760338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p54nrb is a new regulator of progression of malignant melanoma.
    Schiffner S; Zimara N; Schmid R; Bosserhoff AK
    Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
    Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
    Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of MIA protein during melanoma cell migration.
    Schmidt J; Bosserhoff AK
    Int J Cancer; 2009 Oct; 125(7):1587-94. PubMed ID: 19521988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-derived soluble factor enhances melanoma inhibitory activity expression by uveal melanoma cells in vitro.
    Callejo SA; Marshall JC; Cools-Lartigue J; Saraiva VS; Burnier MN
    Melanoma Res; 2004 Apr; 14(2):91-5. PubMed ID: 15057037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
    Bosserhoff AK; Moser M; Hein R; Landthaler M; Buettner R
    J Pathol; 1999 Mar; 187(4):446-54. PubMed ID: 10398105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, function and clinical relevance of MIA (melanoma inhibitory activity).
    Bosserhoff AK; Buettner R
    Histol Histopathol; 2002 Jan; 17(1):289-300. PubMed ID: 11813878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques.
    Jachimczak P; Apfel R; Bosserhoff AK; Fabel K; Hau P; Tschertner I; Wise P; Schlingensiepen KH; Schuler-Thurner B; Bogdahn U
    Int J Cancer; 2005 Jan; 113(1):88-92. PubMed ID: 15386421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected].
    Hau P; Wise P; Bosserhoff AK; Blesch A; Jachimczak P; Tschertner I; Bogdahn U; Apfel R
    J Invest Dermatol; 2002 Sep; 119(3):562-9. PubMed ID: 12230496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of MIA in melanocytes and early development of melanoma.
    Poser I; Tatzel J; Kuphal S; Bosserhoff AK
    Oncogene; 2004 Aug; 23(36):6115-24. PubMed ID: 15208686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.